Cardiol Therapeutics Inc. (TSX:CRDL)

Cardiol Therapeutics Ratios and Metrics

Market cap in millions CAD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 15, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	202	130	151	72	44	142
Market Cap Growth	61.22%	-13.65%	110.34%	63.29%	-69.05%	55.49%
Enterprise Value	175	119	135	31	-21	113
Last Close Price	1.81	1.31	1.85	1.10	0.69	2.33
PS Ratio	-	-	-	-	-	1803.25
PB Ratio	8.37	7.29	6.11	2.54	0.84	1.86
P/TBV Ratio	8.37	7.29	6.11	2.56	0.85	1.87
EV/Sales Ratio	-	-	-	-	-	1441.08
Debt / Equity Ratio	0.01	0.01	0.01	0.01	0.00	0.00
Net Debt / Equity Ratio	-1.14	-1.19	-1.23	-1.23	-1.14	-1.10
Net Debt / EBITDA Ratio	0.78	0.62	0.76	1.18	1.44	2.18
Net Debt / FCF Ratio	1.14	0.89	1.21	1.38	2.18	3.56
Asset Turnover	-	-	-	-	-	0.00
Quick Ratio	3.93	3.83	4.41	4.25	6.12	7.29
Current Ratio	4.39	4.16	4.52	4.36	6.27	7.54
Return on Equity (ROE)	-173.96%	-158.75%	-138.47%	-69.93%	-48.16%	-70.69%
Return on Assets (ROA)	-78.25%	-77.31%	-73.43%	-37.71%	-34.47%	-46.58%
Return on Capital Employed (ROCE)	-146.60%	-191.00%	-162.10%	-104.90%	-79.20%	-50.70%
Earnings Yield	-17.95%	-25.94%	-24.30%	-39.19%	-70.37%	-22.28%
FCF Yield	-11.99%	-18.32%	-16.61%	-35.17%	-62.10%	-16.58%
Buyback Yield / Dilution	-24.11%	-21.55%	-11.02%	-3.13%	-44.61%	-44.77%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.